Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rafael starts Phase III trial of CPI-613 and CHAM to treat AML

Bone marrow aspirate showing acute myeloid leukemia. Credit: VashiDonsk at English Wikipedia.

  • Rafael Pharmaceuticals

Go Top